Vitamin D Receptor Polymorphisms and the Risk of Acute Lower Respiratory Tract Infection in Early Childhood
The Journal of Infectious Diseases, Vol 197, Issue 5, 1 March 2008, Pages 676–680, https://doi.org/10.1086/527488
Daniel E. Roth Adrian B. Jones Connie Prosser Joan L. Robinson Sunita Vohra
Items in both categories Breathing and Vitamin D Receptor are listed here:
- Asthma by age 7 if wheezing before preeschools and poor vitamin D Receptor - May 2023
- 2X increase risk of Asthma if a particular Vitamin D Receptor mutation – meta-analysis Feb 2022
- Atopies (allergy, asthma, rhinitis, etc.) variously associated with low Vitamin D and poor Vitamin D Receptor – Aug 2021
- Mucosal membranes (mouth, lungs, nose, intestines, etc) can activate Vitamin D – July 2020
- Respiratory problems in Children 1.4X more likely if poor Vitamin D receptor – April 2020
- Poor response to Asthma inhaler if poor Vitamin D Receptor – Dec 2019
- Microbiomes of both gut and airway are affected by Vitamin D and Vitamin D Receptor – Nov 2018
- Asthma 3.7X higher risk of poor Vitamin D Receptor (teens in Taiwan in this case) – Nov 2019
- Asthma is 20 percent more likely with a poor Vitamin D Receptor gene – meta-analysis Oct 2019
- Asthmatic children 5X more likely to have a poor Vitamin D Receptor – June 2019
- Best supplements for hay fever (Quercetin, which activates the Vitamin D receptor) - June 2019
- Upper respiratory infection associated with poor Vitamin D Receptor – Oct 2018
- Respiratory Distress Syndrome in preemies 5 X more likely if poor vitamin D receptor – Feb 2019
- Gut and airway bionome are affected by Vitamin D and Vitamin D Receptor – Nov 2018
- Pneumonia in Egyptian Children 3.6 X more likely if poor Vitamin D Receptor – Aug 2018
- Respiratory Tract Infections in children 7.4 X more likely if poor Vitamin D Receptor – 2008
- Inflammation and immune responses to Vitamin D (perhaps need to measure active vitamin D) – July 2017
- Vitamin D Receptor problems occur 5 times for often with Nasal polyposis – Nov 2016
- Vitamin D effects on lung immunity and respiratory diseases – 2011
- Childhood asthma about 1.3 times more likely if poor Vitamin D Receptor – meta-analysis Aug 2016
- Severe Pertussis is 1.5 times more likely if poor vitamin D receptor – Feb 2016
- 2X higher risk of wheezing and asthma if modified receptor genes, even if vitamin D levels OK – Sept 2015
- 2.8X higher risk of osteoporosis if COPD and modified vitamin D receptor genes – Sept 2015
- Strong Vitamin D deficiency associations in Asthma patients – Nov 2014
Vitamin D Receptor category has the following
Vitamin D tests cannot detect Vitamin D Receptor (VDR) problems
A poor VDR restricts Vitamin D from getting in the cells
It appears that 30% of the population have a poor VDR (40% of the Obese )
Several diseases protect themselves by deactivating the Vitamin D receptor. Example: Breast Cancer
- - - - - - - -
The Vitamin D Receptor is associated with many health problems
Some health problems, such as Breast Cancer, Diabetes, and COVID protect themselves by reducing VDR activation
A poor VDR is associated with the risk of 55 health problems click here for details
The risk of 48 diseases at least double with poor VDR as of Jan 2023 click here for details
Some health problem, such as Breast Cancer reduce the VDR
VDR at-home test $29 - results not easily understood in 2016
There are hints that you may have inherited a poor VDR
Compensate for poor VDR by increasing one or more:
|1) Vitamin D supplement Sun|
| Vitamin D in the blood |
and thus in the cells
|2) Magnesium||Vitamin D in the blood |
AND in the cells
|3) Omega-3||Vitamin D in the cells|
|4) Resveratrol||Vitamin D Receptor|
|5) Intense exercise||Vitamin D Receptor|
|6) Get prescription for VDR activator|
|Vitamin D Receptor|
|7) Quercetin (flavonoid)||Vitamin D Receptor|
|8) Zinc is in the VDR||Vitamin D Receptor|
|9) Boron||Vitamin D Receptor ?, |
|10) Essential oils e.g. ginger, curcumin||Vitamin D Receptor|
|11) Progesterone||Vitamin D Receptor|
|12) Infrequent high concentration Vitamin D|
Increases the concentration gradient
|Vitamin D Receptor|
|13) Sulfroaphane and perhaps sulfur||Vitamin D Receptor|
|14)Butyrate especially gut||Vitamin D Receptor|
Note: If you are not feeling enough benefit from Vitamin D, you might try increasing VDR activation. You might feel the benefit within days of adding one or more of the above
Far healthier and stronger at age 72 due to supplements Includes 6 supplements that help the VDR
Increased risk associated with a poor Vitamin D Receptor
Note: Some diseases reduce VDR activation
those with a * are known to decrease activation
Risk Ratio (the left side of Table 2)
To investigate associations of 2 vitamin D receptor (VDR) gene polymorphisms and acute lower respiratory tract infection (ALRI),wecompared 56 young children hospitalized with ALRI and 64 children without a history of ALRI. The FokI ff genotype was associated with an adjusted relative odds of ALRI that was ∼7 times that of FokI FF. A weaker association with the TaqI polymorphism was also found. These data provide preliminary evidence of associations of VDR polymorphisms with the risk of ALRI (predominantly viral bronchiolitis) in young children, consistent with a potential role of vitamin D in the immune response to respiratory tract infection.
Topic: polymorphism immune response viral bronchiolitis child genes genotype vitamin d3 receptor respiratory tract infections vitamin d respiratory tract infection, lower, acute
The active metabolite of vitamin D, 1,25-dihydroxyvitamin D, has potent immunomodulatory actions via binding to the vitamin D receptor (VDR) and may influence the immune response to viral infections . In North America, acute lower respiratory tract infection (ALRI) during early childhood usually has a viral etiology, most commonly respiratory syncytial virus (RSV). Clinical manifestations of RSV ALRI are mainly due to immunopathogenic mechanisms, suggesting that modulation of the host immune response is a potential approach to disease prevention or management .
To explore the hypothesis that vitamin D is implicated in the host response to childhood ALRI, we compared the distributions of 2 single-nucleotide polymorphisms (SNPs) in the gene encoding the VDR among young children admitted to the hospital for ALRI and among healthy control subjects. These SNPs, identified by the TaqI and FokI restriction endonucleases, have been previously associated with the risk or severity of pulmonary tuberculosis in adults in some but not all populations studied [3, 4]. This study was a planned secondary analysis in a case-control study for which the primary association of interest was 25- hydroxyvitamin D concentration and ALRI risk.
Subjects, materials, and methods. Participants were recruited at the Stollery Children's Hospital in Edmonton, Canada (latitude 53°N), from 1 January through 31 March in 2005 and 2006. Cases were patients aged 1–24 months admitted with ALRI, clinically defined as bronchiolitis (rhinorrhea, coryza, cough, and/or fever of <2 weeks duration; wheezes and/or crackles on auscultation of the lung fields; and increased respiratory effort) or pneumonia (temperature of >38.0°C, respiratory distress, and consolidation or pleural effusion on a chest radiograph). Bronchiolitis and pneumonia cases were analyzed together because there is substantial clinical overlap between the 2 conditions and because both were likely to have a viral etiology in this setting. Cases were excluded if they had underlying conditions (e.g., pulmonary aspiration, oropharyngeal abnormality, or symptomatic congenital heart disease) that could complicate an ALRI. Controls were children aged 1 month to 2 years admitted for elective surgery who did not have any history of hospital admission for ALRI or any of the conditions used as exclusion criteria for the cases.
Analysis of VDR restriction fragment length polymorphisms (RFLPs) was performed in the Department of Pathology at the University of Alberta Hospital (Edmonton, Canada). Venous whole blood specimens were collected in EDTA tubes and stored at −20°C until processing. DNA was extracted from 200 µL of whole blood using the QIAamp DNA Blood Mini Kit (Qiagen). DNA sequences containing 2 previously described VDR SNPs identified by TaqI (rs731236)  and FokI (rs10735810)  were amplified by PCR according to methods adapted from those described elsewhere . The presence of a restriction site was designated by a lowercase letter and its absence by an uppercase letter: “t” and “T” were used for the TaqI site, and “f” and “F” were used for the FokI site. Duplicate genotyping was performed on randomly selected samples to ensure reproducibility. The PCR-RFLP assays and assignments of genotypes were performed without knowledge of the participant identity or group.
The parent and/or caregiver of each participant provided informed consent and completed a written questionnaire concerning participant and family characteristics. The study was approved by the Human Research Ethics Board of the University of Alberta Health Sciences Faculties. Parents could refuse genetic testing but participate in other parts of the study.
Maternal and paternal ethnicity were reported by caregivers as Aboriginal Canadian (i.e., First Nations, Inuit, or Métis), white (i.e., European or Caucasian), Chinese or East Asian, Indian (i.e., south Asian), Hispanic (i.e., Caribbean, Mexican, or Central or South American), black African, Middle Eastern, or other. For analysis, participants were divided into 1 of 4 categories, according to their parents' ethnicity: both Aboriginal Canadian, both white, 1 Aboriginal Canadian and 1 white, and other.
Differences in continuous variables were assessed by the Student t test for independent samples. Differences in proportions were assessed by means of the 2-tailed Fisher exact test. Hardy- Weinberg equilibrium was tested using the genhwcci command in Stata. Analyses were conducted using genotype as the independent variable, whereby the genotype homozygous for the 2 common alleles (T or F) served as the reference category. Logistic regression analysis was performed to obtain odds ratios and 95% confidence intervals for the association between VDR genotypes and ALRI, using unadjusted, ethnicity adjusted, and fully adjusted multivariate models. The latter model included the following covariates assumed to be confounders in the source population: age, sex, maternal and paternal education level (defined binarily as completion or noncompletion of high school), household crowding (defined as the number of people per bedroom), exclusive breastfeeding to 4 months of age, maternal smoking during pregnancy, and number of smokers in the home. To further minimize population stratification (confounding by ethnicity), the analysis was repeated in a subsample of participants with 2 white parents. A 2-sided P value of <.05 was considered to be statistically significant. Statistical analyses were conducted using Intercooled Stata, version 9.2 for Windows (Stata).
Results. Of 172 hospitalized children with ALRI, 116 were excluded from enrollment because a caregiver could not be contacted (22%), consent was refused (54%), exclusion criteria were present (9%), or a suitable blood specimen was unavailable (15%). The age and sex distributions of participating and nonparticipating cases were very similar (data not shown).
Of the 56 cases enrolled, 52 had bronchiolitis, and 4 had pneumonia. Routine viral analysis of nasopharyngeal aspirates revealed that 46 cases (82%) had RSV, 4 (7%) had parainfluenza or adenovirus, and 6 (11%) did not have a detectable virus. Compared with the 64 control participants enrolled, cases were younger, more likely to have an Aboriginal Canadian parent, and had a higher probability of reporting several conventional ALRI risk factors (table 1). The subsample of subjects with 2 white parents included 25 cases and 56 controls.
Characteristics and vitamin D receptor (VDR) polymorphisms in healthy controls and in cases with acute lower respiratory tract infection, overall and in a subsample with 2 white parents.
The f allele was overrepresented among children with 2 Aboriginal Canadian parents (FF, 15%; Ff, 60%; and ff, 25%), compared with its representation among children with 2 white parents (FF, 33%; Ff, 58%; and ff, 9% [P = .062]). However, the TaqI genotypic distributions in the group with 2 Aboriginal Canadian parents (TT, 65%; Tt, 30%; and tt, 5%) were to similar to those in the group with 2 white parents (TT, 44%; Tt, 48%; and tt, 7% [P = .595]).
The distribution of TaqI polymorphisms was similar among case and control groups in the complete sample but differed in the subsample (table 1). There was a statistically significant association between the TaqI Tt genotype and the odds of ALRI in the crude and adjusted analysis in the subsample but not in the complete sample (table 2).
The FokI distributions were different between the case and control groups in both the complete sample and the subsample (table 1). In both the overall population and the subsample, the odds of ALRI for a child with the ff genotype were significantly increased relative to those for a child with the FF genotype in unadjusted and adjusted analyses (table 2). Effect sizes were similar and inferences unchanged upon exclusion of the subjects with pneumonia from the complete and subsample (data not shown).
Analysis of the association between vitamin D receptor (VDR) genotypes and the risk of acute lower respiratory tract infection, overall and in a subsample of children with 2 white parents.
Discussion. Among young Canadian children, a functionaltering SNP in the gene that encodes the VDR (i.e., FokI) was strongly associated with the risk of ALRI (predominantly RSV bronchiolitis). This association remained statistically significant after adjusting for ethnicity and other potential confounders. Within a subgroup with relative ethnic homogeneity (i.e., participants with 2 white parents), although the small sample size resulted in imprecise point estimates for the odds ratio, the confidence intervals excluded the null, suggesting that the FokI-ALRI association was unlikely to have occurred by chance. There was a weaker and less consistent association of ALRI risk with an SNP (TaqI) that does not alter the VDR polypeptide.
These findings are consistent with the hypothesis that vitamin D—related pathways are implicated in the host immune response to viral respiratory infection . Furthermore, previous evidence suggests that an increased risk of ALRI associated with the ff genotype is biologically plausible. The f allele translates a VDR protein that is longer than that translated by the F allele and has decreased rates of transcription of VDR RNA . In peripheral blood mononuclear cell (PBMC) cultures, the concentration of 1,25-dihydroxyvitamin D (1,25(OH)2D) required to cause 50% growth inhibition was directly related to the number of f alleles , and in vitro lymphoproliferation caused by exposure to mycobacterial antigen was more likely to be inhibited by 1,25(OH)2D if the cells expressed the FF genotype . These observations suggest that, although the f allele encodes a less active VDR and may affect the host's ability to use vitamin D for antimicrobial activities or regulation of the inflammatory response, higher circulating 25(OH)D concentrations could theoretically overcome its hypofunctionality. Although some of the previous studies have suggested codominance (i.e., dose response with increasing copies of the f allele), the present study sample was too small to detect a significant effect of a single f allele.
An association of ALRI risk with the TaqI Tt genotype but not the tt genotype emerged in the adjusted analysis of the complete sample and in subsample. The TaqI polymorphism has previously been linked to susceptibility to infectious diseases, including tuberculosis . Although the TT genotype has been associated with levels of VDR expression in PBMCs that are higher than those for the tt genotype , the implications of TaqI polymorphisms for immune function are not known. In the present study, carriers of a single t allele curiously appeared to be at greater risk of ALRI than those with 2 t alleles; however, the estimated odds ratio for the tt genotype may have been unstable because of a low number of participants in that genotype group.
There are several candidate mechanisms by which activated vitamin D binding to the VDR could modulate viral lower respiratory tract disease, including down-regulation of the toll-like receptor 4  to which RSV binds , suppression of T cell proliferation  or tumor necrosis factor-α synthesis , or stimulation of the production of an antimicrobial host protein . Subclinical vitamin D deficiency was a significant independent risk factor for severe ALRI in children in India aged <5 years ; however, among the relatively vitamin D—replete participants in the present study, we did not find that 25-hydroxyvitamin D concentrations were associated with the risk of ALRI .
There were several methodological limitations in this study. First, it is possible that the finding of an association between the ff genotype and ALRI risk resulted from a low prevalence of the ff genotype in the control group that occurred by chance or nonrandom control selection; however, compared with the FokI genotype distribution previously reported among white northern Europeans (FF, 42%; Ff, 43%; and ff, 16%) , the prevalence of the f allele was relatively high (80%) among the cases in the subsample in this study. An important potential cause of confounding was that children with 2 Aboriginal Canadian parents were more likely to carry the f allele, were overrepresented among the cases, and had a higher probability of experiencing most of the traditional environmental risk factors for ALRI (data not shown). Regression analyses were adjusted to minimize population stratification and confounding by environmental risk factors; however, because there were no quantitative measures of population admixture, undetected heterogeneity between the groups may have caused confounding. An additional consideration is the possibility that the observed association was due to an association of ALRI with a nearby locus to which the VDR is closely linked. Finally, the sample size was small, leading to imprecise estimates (i.e., wide confidence intervals). The findings should thus be treated as preliminary, because false-positive associations are relatively common in case-control studies of genetic association.
In summary, the observed associations between VDR SNPs and the risk of ALRI in young Canadian children are consistent with the notion that vitamin D modulates the immune response to viral respiratory tract infections. Confirmation of these results in a larger sample, as well as further elaboration of the effect of interplay between circulating vitamin D metabolites and the VDR on the host response to ALRI, are required before firm conclusions can be drawn about the clinical or public health importance of these findings.
|4073 visitors, last modified 11 Feb, 2018,